• Теги
    • избранные теги
    • Компании2641
      • Показать ещё
      • Показать ещё
      Страны / Регионы479
      • Показать ещё
      Международные организации57
      • Показать ещё
      • Показать ещё
      • Показать ещё
      • Показать ещё
Выбор редакции
27 мая, 00:44

GSK among biggest gainers as weak pound lifts FTSE 100

Power brands in venture with Novartis deliver high sales growth on improving margins

Выбор редакции
25 мая, 17:14

Brief Study of American Beacon International Equity Fund Investor (AAIPX)

American Beacon International Equity Fund Investor (AAIPX) seeks long-term capital appreciation

25 мая, 14:43

Alnylam Pharmaceuticals (ALNY) Progressing Well on Pipeline

We issued an updated research report on Alnylam Pharmaceuticals, Inc. (ALNY) on May 23, 2017.

Выбор редакции
25 мая, 14:11

Novartis (NVS) Reports Positive Data on Ultibro Breezhaler

Novartis AG (NVS) announced positive data from the FLAME study on COPD drug, Ultibro Breezhaler.

23 мая, 19:18

Here's Why Alexion Pharma (ALXN) Stock is Sinking Today

On Tuesday, shares of Alexion Pharmaceuticals Inc. (ALXN) are sinking, down over about 8.5% in mid-morning trading after the company announced a series of changes to its executive team.

23 мая, 00:53

Novartis' (NVS) Lung Cancer Drug Gets Positive CHMP Opinion

Novartis (NVS) recently announced that the CHMP of the European Medicines Agency (EMA) has recommended the approval of a label expansion of Zykadia.

19 мая, 17:20

Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab

Amgen Inc. (AMGN) recently announced the submission of a biologics license application (BLA) to the FDA for its pipeline candidate erenumab (AMG 334) for the prevention of migraine.

Выбор редакции
Выбор редакции
16 мая, 19:01

A ‘magnet’ for research and development

AFTER living in the US for 22 years, Larry Zhang was posted to Singapore in 2009 for a working assignment. He and his family moved to Shanghai in July 2011 after Zhang was appointed chief executive officer

12 мая, 15:49

Pharma Stock Roundup: Mylan, Teva Q1 Earnings, Roche Drug Misses in Pivotal Study

While companies like Mylan (MYL), Allergan and Teva reported Q1 results this week, several companies provided updates on their cancer drugs.

12 мая, 14:34

Teva (TEVA) Q1 Earnings In Line, Sales Lag as Copaxone Falls

Teva Pharmaceutical Industries Ltd. (TEVA) reported first-quarter 2017 earnings of $1.03 per share (including equity compensation expenses), which was in line with the Zacks Consensus Estimate.

10 мая, 20:56

Model N (MODN) Q2 Loss Narrower than Expected, Guides Well

Model N, Inc. (MODN) reported second-quarter 2017 adjusted loss of 25 cents per share, which was wider than the year-ago quarter's loss of 21 cents.

Выбор редакции
10 мая, 17:06

Ligand Pharmaceuticals (LGND) Q1 Earnings Miss Estimates

Ligand Pharmaceuticals Incorporated (LGND) reported first-quarter 2017 earnings of 31 cents per share (including the impact of stock-based compensation expenses), down 32.5% from the year-ago figure.

10 мая, 15:30

Biotech Stock Roundup: Regeneron, BioMarin Report Q1, Kite Down on Patient Death

Kite's (KITE) shares were hit by news regarding a patient death resulting from cerebral edema.

08 мая, 21:59

Incyte (INCY) Q1 Loss Narrower than Expected, Revenues Beat

Incyte's first-quarter results were encouraging as the company reported a narrower-than-expected loss and surpassed revenue expectations.

08 мая, 15:46

Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit

Major pharma companies like Pfizer (PFE) and Merck reported Q1 results last week.

Выбор редакции
Выбор редакции
07 мая, 21:06

Barron's Picks And Pans: Amazon, Novartis, Tesla And More

This weekend's Barron's takes a look at why the king of e-commerce must avoid becoming too profitable. Other featured articles offer the prospects for retail stocks that benefit from woes in the sector ...